PharmaTher Holdings Ltd. (CSE: PHRM; OTCQB: PHRRF) is a specialty pharmaceutical and technology company focused on developing, acquiring and commercializing pharmaceutical products and enabling technologies. The Company is advancing MEDBOTX™, a robotic 3D printing platform designed for personalized medicine, peptides and advanced dose formats, while continuing to evaluate strategic opportunities for its ketamine portfolio, PharmaPatch™ psychedelics research, and interest in Sairiyo Therapeutics Inc. For more information, visit PharmaTher.com.